Two Watertown biotechs raise $130m in IPOs – Boston Globe
By Dr. Matthew Watson
 The Deal Pipeline | Two Watertown biotechs raise $130m in IPOs Boston Globe A pair of Watertown biotechnology start-ups together raised more than $130 million through initial public offerings this week, a sign that the long-sluggish IPO market may be rebounding. But investor appetite for the newly public companies diverged ... Enanta Pharmaceuticals Announces IPO pricingPrivate Equity Hub (press release) Tetraphase shares unchanged on first day of trading after $75 million IPOBostonglobe Enanta, Tetraphase fare differently in market debutsThe Deal Pipeline |
Uncategorized
Comments Off on Two Watertown biotechs raise $130m in IPOs – Boston Globe |
March 24th, 2013
This author published 5492 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research